22.11.2014 Views

NORTH-SOUTH CENTRE - ETH - North-South Centre North-South ...

NORTH-SOUTH CENTRE - ETH - North-South Centre North-South ...

NORTH-SOUTH CENTRE - ETH - North-South Centre North-South ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Whole genome profiling of<br />

Theileria parva isolates<br />

East Coast Fever (ECF) is a fatal bovine lympho-proliferative<br />

disease endemic in sub-Saharan Africa. Twenty-eight million<br />

cattle are at risk of contracting the disease. It results in<br />

the death of at least one million cattle, causing economic<br />

losses of about 200 million dollars annually. In sub-Saharan<br />

Africa, the disease is primarily controlled by the use of<br />

chemical acaricides. However, this is becoming unsustainable<br />

due to high costs, increasing risks of emergence of acaricide-resistant<br />

tick strains, and the retention of toxic residues<br />

of the chemicals in meat, milk and the environment.<br />

The infection and treatment method (ITM) of immunisation<br />

is a medium-term sustainable method increasingly<br />

being adopted by farmers in East, Central and <strong>South</strong>ern<br />

Africa. It involves inoculation of cattle with a near-lethal<br />

dose of live sporozoites of Theileria parva – the causative<br />

agent of ECF – along with a high dose of oxytetracycline to<br />

control the infection. One mixture of T. parva stocks that<br />

is increasingly used by local farmers is the Muguga cocktail.<br />

It comprises three stocks of T. parva: Muguga, Kiambu 5 and<br />

Serengeti-transformed. In this project, we will sequence<br />

the whole genomes of eight strains of T. parva, including<br />

the components of the Muguga cocktail and two buffaloderived<br />

strains, using the high throughput 454 sequencing<br />

technology.<br />

So far, the focus of the project has been on sequencing<br />

material preparation. Genomic DNA of T. parva Uganda,<br />

Marikebuni and Uganda/Muguga recombinant have been<br />

derived successfully and are being sequenced. Samples for<br />

the T. parva Kiambu-5 isolate are being prepared at ILRI.<br />

The genome of the Serengeti-transformed isolate has<br />

recently been sequenced by the 454 method using a combination<br />

of paired-end and shotgun libraries. It has been<br />

assembled into 32 contigs using the published T. parva<br />

Muguga genome as a template. Annotation against<br />

T. parva Muguga genome using sequence comparison<br />

methods such as BLAST algorithms 1 is underway.<br />

After sequencing Kiambu-5, we will compare the three vaccine<br />

components in order to gain insight into the genes<br />

that might contribute towards the efficiency of the ITM.<br />

From the sequences we will identify (i) highly conserved<br />

and rapidly evolving genes, (ii) genes under positive selection<br />

that would relate to host-parasite interactions, and<br />

(iii) SNPs for micro-epidemiological studies. The genome<br />

sequences of the other parasite isolates will enable us to<br />

study evolutionary forces driving parasite diversity also on<br />

the level of sexual recombination.<br />

1 Basic Local Alignment Search Tool algorithms<br />

Research fellow<br />

Sonal Patel, ILRI, Kenya<br />

81<br />

Supervisors<br />

Claudia Daubenberger, STI, Switzerland;<br />

Richard Bishop, ILRI, Kenya<br />

Collaborators<br />

Weihong Qi, University of Zurich, Switzerland;<br />

Etienne de Villiers, ILRI, Kenya<br />

Duration<br />

August 2009 – July 2012<br />

Capacity development<br />

Research fellowships<br />

The infection and treatment method vaccine<br />

being administered to a pastoralist‘s calf

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!